168 related articles for article (PubMed ID: 24969354)
1. Oral drug delivery of therapeutic gases - carbon monoxide release for gastrointestinal diseases.
Steiger C; Lühmann T; Meinel L
J Control Release; 2014 Sep; 189():46-53. PubMed ID: 24969354
[TBL] [Abstract][Full Text] [Related]
2. Prevention of colitis by controlled oral drug delivery of carbon monoxide.
Steiger C; Uchiyama K; Takagi T; Mizushima K; Higashimura Y; Gutmann M; Hermann C; Botov S; Schmalz HG; Naito Y; Meinel L
J Control Release; 2016 Oct; 239():128-36. PubMed ID: 27578097
[TBL] [Abstract][Full Text] [Related]
3. Investigation of orally delivered carbon monoxide for postoperative ileus.
Van Dingenen J; Steiger C; Zehe M; Meinel L; Lefebvre RA
Eur J Pharm Biopharm; 2018 Sep; 130():306-313. PubMed ID: 30006245
[TBL] [Abstract][Full Text] [Related]
4. Oral Use of Therapeutic Carbon Monoxide for Anyone, Anywhere, and Anytime.
Reiländer S; Schmehl W; Popp K; Nuss K; Kronen P; Verdino D; Wiezorek C; Gutmann M; Hahn L; Däubler C; Meining A; Raschig M; Kaiser F; von Rechenberg B; Scherf-Clavel O; Meinel L
ACS Biomater Sci Eng; 2023 Jun; 9(6):2937-2948. PubMed ID: 36444758
[TBL] [Abstract][Full Text] [Related]
5. Carbon monoxide-releasing micelles for immunotherapy.
Hasegawa U; van der Vlies AJ; Simeoni E; Wandrey C; Hubbell JA
J Am Chem Soc; 2010 Dec; 132(51):18273-80. PubMed ID: 21128648
[TBL] [Abstract][Full Text] [Related]
6. Intracellular CO release from composite of ferritin and ruthenium carbonyl complexes.
Fujita K; Tanaka Y; Sho T; Ozeki S; Abe S; Hikage T; Kuchimaru T; Kizaka-Kondoh S; Ueno T
J Am Chem Soc; 2014 Dec; 136(48):16902-8. PubMed ID: 25352251
[TBL] [Abstract][Full Text] [Related]
7. The Interaction of CORM-2 with Block Copolymers Containing Poly(4-vinylpyridine): Macromolecular Scaffolds for Carbon Monoxide Delivery in Biological Systems.
Nguyen D; Adnan NN; Oliver S; Boyer C
Macromol Rapid Commun; 2016 May; 37(9):739-44. PubMed ID: 26945898
[TBL] [Abstract][Full Text] [Related]
8. Sulfite species enhance carbon monoxide release from CO-releasing molecules: implications for the deoxymyoglobin assay of activity.
McLean S; Mann BE; Poole RK
Anal Biochem; 2012 Aug; 427(1):36-40. PubMed ID: 22561917
[TBL] [Abstract][Full Text] [Related]
9. Lipid-encapsulated upconversion nanoparticle for near-infrared light-mediated carbon monoxide release for cancer gas therapy.
Opoku-Damoah Y; Zhang R; Ta HT; Amilan Jose D; Sakla R; Xu ZP
Eur J Pharm Biopharm; 2021 Jan; 158():211-221. PubMed ID: 33276086
[TBL] [Abstract][Full Text] [Related]
10. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
[TBL] [Abstract][Full Text] [Related]
11. Controlled therapeutic gas delivery systems for quality-improved transplants.
Steiger C; Wollborn J; Gutmann M; Zehe M; Wunder C; Meinel L
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):96-106. PubMed ID: 26527426
[TBL] [Abstract][Full Text] [Related]
12. A contribution to the rational design of Ru(CO)3Cl2L complexes for in vivo delivery of CO.
Seixas JD; Santos MF; Mukhopadhyay A; Coelho AC; Reis PM; Veiros LF; Marques AR; Penacho N; Gonçalves AM; Romão MJ; Bernardes GJ; Santos-Silva T; Romão CC
Dalton Trans; 2015 Mar; 44(11):5058-75. PubMed ID: 25427784
[TBL] [Abstract][Full Text] [Related]
13. Developing drug molecules for therapy with carbon monoxide.
Romão CC; Blättler WA; Seixas JD; Bernardes GJ
Chem Soc Rev; 2012 May; 41(9):3571-83. PubMed ID: 22349541
[TBL] [Abstract][Full Text] [Related]
14. Dicarbonyl-bis(cysteamine)iron(II): a light induced carbon monoxide releasing molecule based on iron (CORM-S1).
Kretschmer R; Gessner G; Görls H; Heinemann SH; Westerhausen M
J Inorg Biochem; 2011 Jan; 105(1):6-9. PubMed ID: 21134596
[TBL] [Abstract][Full Text] [Related]
15. A photochemical precursor for carbon monoxide release in aerated aqueous media.
Rimmer RD; Richter H; Ford PC
Inorg Chem; 2010 Feb; 49(3):1180-5. PubMed ID: 20039612
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
[TBL] [Abstract][Full Text] [Related]
17. Bioactive properties of iron-containing carbon monoxide-releasing molecules.
Sawle P; Hammad J; Fairlamb IJ; Moulton B; O'Brien CT; Lynam JM; Duhme-Klair AK; Foresti R; Motterlini R
J Pharmacol Exp Ther; 2006 Jul; 318(1):403-10. PubMed ID: 16603670
[TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-β/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages.
Tsoyi K; Nizamutdinova IT; Jang HJ; Mun L; Kim HJ; Seo HG; Lee JH; Chang KC
Shock; 2010 Dec; 34(6):608-14. PubMed ID: 20442692
[TBL] [Abstract][Full Text] [Related]
19. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
[TBL] [Abstract][Full Text] [Related]
20. The Intercalation of CORM-2 with Pharmaceutical Clay Montmorillonite (MMT) Aids for Therapeutic Carbon Monoxide Release.
Faizan M; Niazi KUK; Muhammad N; Hu Y; Wang Y; Lin D; Liu Y; Zhang W; Gao Z
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
